The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochemical Journal

• Publication date

  1996-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ3140701PMID 8670088PMCID PMC1217103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid P Component Promotes Aggregation of Alzheimer′s β-Amyloid Peptide

  1995cited by this paper
• Two conformational states of amyloid β-peptide: implications for the pathogenesis of Alzheimer's disease

  1995cited by this paper
• Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure

  1995cited by this paper
• The -Helical to -Strand Transition in the Amino-terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation *

  1995cited by this paper
• Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

  1995cited by this paper
• Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

  1995cited by this paper
• Amyloid P component promotes aggregation of Alzheimer's beta-amyloid peptide.

  1995cited by this paper
• Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

  1994cited by this paper
• Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.

  1994cited by this paper
• Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

  1994cited by this paper
• Alzheimer's disease and soluble Aβ

  1994cited by this paper
• Modeling studies of the change in conformation required for cleavage of limited proteolytic sites

  1994cited by this paper
• Structural determinants of the Alzheimer's amyloid beta-peptide.

  1994cited by this paper
• The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils.

  1994cited by this paper
• Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.

  1994cited by this paper
• Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.

  1994cited by this paper
• Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.

  1994cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• Alzheimer's disease and soluble A beta.

  1994cited by this paper
• Solution structure of residues 1-28 of the amyloid beta-peptide.

  1994cited by this paper
• Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

  1994cited by this paper
• Structural Determinants of the Alzheimer's Amyloid β‐Peptide

  1994cited by this paper
• An interaction of beta-amyloid with aluminium in vitro.

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

  1993cited by this paper
• Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

  1993cited by this paper
• An interaction of β‐amyloid with aluminium in vitro

  1993cited by this paper
• Comparative Analysis of Human and Dutch-Type Alzheimer β-Amyloid Peptides by Infrared Spectroscopy and Circular Dichroism

  1993cited by this paper
• Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism.

  1993cited by this paper
• Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

  1992cited by this paper
• Toxicity of synthetic A beta peptides and modeling of Alzheimer's disease.

  1992cited by this paper
• β-amyloid peptide in vitro toxicity: Lot-to-lot variability

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide.

  1992cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.

  1992cited by this paper
• Effects of Sulfate Ions on Alzheimer β/A4 Peptide Assemblies: Implications for Amyloid Fibril‐Proteoglycan Interactions

  1992cited by this paper
• NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.

  1992cited by this paper
• Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin.

  1992cited by this paper
• Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.

  1992cited by this paper
• Toxicity of synthetic aβ peptides and modeling of alzheimer's disease

  1992cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

  1991cited by this paper
• Kinetic analysis of amyloid fibril polymerization in vitro.

  1991cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Molecular biology of Alzheimer's disease.

  1989cited by this paper
• 1H NMR studies of the solution conformations of an analogue of the C-peptide of ribonuclease A.

  1989cited by this paper
• Conformation of peptide fragments of proteins in aqueous solution: implications for initiation of protein folding.

  1988cited by this paper
• Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn.

  1988cited by this paper
• Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern.

  1987cited by this paper
• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

  1987cited by this paper
• In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

  1986cited by this paper
• In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• Formation and structure of gels and fibrils from glucagon.

  1969cited by this paper

• In silico analysis of fungal prion-like proteins for elucidating their role in plant-fungi interactions

  2024cites this paper
• Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research.

  2024cites this paper
• Understanding Osaka mutation polymorphic Aβ fibril response to static and oscillating electric fields: insights from computational modeling

  2024cites this paper
• Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders

  2023cites this paper
• Insights into the in vitro digestibility of pork myofibrillar protein with different ionic polysaccharides from the perspective of gel characteristics.

  2023cites this paper
• Different tau fibril types reduce prion level in chronically and de novo infected cells

  2023cites this paper
• Effects of salt and heat treatment on the physicochemical properties, microstructure, secondary structure and simulated in vitro gastrointestinal digestion of duck egg white.

  2021cites this paper
• Effects of thermal, non-thermal and emulsification processes on the gastrointestinal digestibility of egg white proteins

  2021cites this paper
• Peptides derived from gp43, the most antigenic protein from Paracoccidioides brasiliensis, form amyloid fibrils in vitro: implications for vaccine development

  2021cites this paper
• Protease Resistance of ex vivo Amyloid Fibrils implies the proteolytic Selection of disease-associated Fibril Morphologies

  2021cites this paper
• Amyloid Proteins in Plant-Associated Microbial Communities

  2021cites this paper
• Synthesis of novel 4-methylthiocoumarin and comparison with conventional coumarin derivative as a multi-target-directed ligand in Alzheimer’s disease

  2020cites this paper
• Insulin Hot-Spot Analogs Formed with N-Methylated Amino Acid Residues Inhibit Aggregation of Native Hormone

  2019cites this paper
• Unravelling the role of amino acid sequence order in the assembly and function of the amyloid-β core.

  2019cites this paper
• Search for New Aggregable Fragments of Human Insulin

  2019cites this paper
• In vitro pepsin digestion of silver carp (Hypophthalmichthys molitrix) surimi gels after cross-linking by Microbial Transglutaminase (MTGase)

  2019cites this paper
• Relationship between protein structure changes and in vitro digestion of preserved egg white during pickling.

  2019cites this paper
• A Mechanistic Understanding of Self-Propagating Amyloid-β Oligomer Conformations in Alzheimer Disease

  2018cites this paper
• Tryptophan-Containing Dual Neuroprotective Peptides: Prolyl Endopeptidase Inhibition and Caenorhabditis elegans Protection from β-Amyloid Peptide Toxicity

  2018cites this paper
• Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

  2018cites this paper
• POLY-L-LYSINE DISSOLVES FIBRILLAR AGGREGATION OF THE ALZHEIMER BETA-AMYLOD PEPTIDE IN WITRO FIELD OF THE INVENTION

  2017cites this paper
• AMYLOD BETAPEPTIDE PROTOFIBRLS AND USES THEREOF

  2017cites this paper
• Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.

  2017cites this paper
• The structural properties of egg white gels impact the extent of in vitro protein digestion and the nature of peptides generated

  2016cites this paper
• Amyloid β-peptides interfere with mitochondrial preprotein import competence by a coaggregation process

  2016cites this paper
• The C-terminus hot spot region helps in the fibril formation of bacteriophage-associated hyaluronate lyase (HylP2)

  2015cites this paper
• Role of monomer arrangement in the amyloid self-assembly.

  2015cites this paper
• Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer’s Disease

  2015cites this paper
• Supramolecular Glycosylation Accelerates Proteolytic Degradation of Peptide Nanofibrils

  2015cites this paper
• A brief overview of amyloids and Alzheimer's disease

  2014cites this paper
• The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin

  2014cites this paper
• Melatonin in Alzheimer’s Disease

  2013cites this paper
• Does the Protein Aggregation State Affect the Digestibility and Safety of Foods

  2013cites this paper
• The effect of gel structure on the kinetics of simulated gastrointestinal digestion of bovine β-lactoglobulin.

  2012cites this paper
• Computational modeling of the relationship between amyloid and disease

  2012cites this paper
• Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.

  2012cites this paper
• Modulation of beta-amyloid aggregation by engineering the sequence connecting beta-strand forming domains.

  2012cites this paper
• Analysis of Sol-Gel Encapsulated Aggregate-Prone Peptides by Circular Dichroism

  2012cites this paper
• Characterization of the Amyloidogenic Peptides Amylin & PAP248-286

  2012cites this paper
• Techniques for monitoring protein misfolding and aggregation in vitro and in living cells

  2012cites this paper
• Concentration‐dependent transitions govern the subcellular localization of islet amyloid polypeptide

  2012cites this paper
• STITCHER: Dynamic assembly of likely amyloid and prion beta-structures from secondary structure predictions

  2011cites this paper
• CD measurements of β-amyloid (1-40) and (1-42) in the condensed phase.

  2011cites this paper
• Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels*

  2011cites this paper
• Changes with Age in the Activities of β‐Secretase and the Aβ‐Degrading Enzymes Neprilysin, Insulin‐Degrading Enzyme and Angiotensin‐Converting Enzyme

  2010cites this paper
• High stability of self‐assembled peptide nanowires against thermal, chemical, and proteolytic attacks

  2010cites this paper
• The role of microglia in amyloid clearance from the AD brain

  2010cites this paper
• Exploration of the mechanism for LPFFD inhibiting the formation of β-sheet conformation of Aβ(1–42) in water

  2010cites this paper
• The chemistry of Alzheimer's disease.

  2009cites this paper
• Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation

  2009cites this paper
• Prediction of parallel in-register amyloidogenic beta-structures In highly beta-rich protein sequences by pairwise propensity analysis

  2009cites this paper
• Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide

  2009cites this paper
• BETASCAN: Probable β-amyloids Identified by Pairwise Probabilistic Analysis

  2009cites this paper
• Shear flow promotes amyloid-{beta} fibrilization.

  2009cites this paper
• Inhibitory effect of citrate on Alzheimer's β-amyloid fibrils in vitro

  2009cites this paper
• Structural analysis of human serum albumin complexes with cationic lipids.

  2009cites this paper
• Development of a diagnostic tool to determine global activity of CSF on amyloid beta aggregation

  2008cites this paper
• Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment

  2007cites this paper
• Binding of Proteases to Fibrillar Amyloid-β Protein and its Inhibition by Congo Red

  2007cites this paper
• Time-dependent DNA condensation induced by amyloid beta-peptide.

  2007cites this paper
• Disrupting beta-amyloid aggregation for Alzheimer disease treatment.

  2007cites this paper
• Design of Inhibitors of Amyloid-β Misfolding and Aggregation for Alzheimer's Therapy

  2007cites this paper
• Pharmacological mechanisms in Alzheimer's therapeutics

  2007cites this paper
• Role of A β Transport and Clearance in the Pathogenesis and Treatment of Alzheimer’s Disease

  2007cites this paper
• Time-Dependent DNA Condensation Induced by Amyloid β-Peptide

  2007cites this paper
• Regression stage senile plaques in the natural course of Alzheimer’s disease

  2006cites this paper
• Conformational change and assembly through edge beta strands in transthyretin and other amyloid proteins.

  2006cites this paper
• Binding of trypsin to fibrillar amyloid beta-protein.

  2006cites this paper
• Role of melatonin in Alzheimer-like neurodegeneration

  2006cites this paper
• Role of aggregation conditions and presence of small heat shock proteins on abeta structure, stability and toxicity

  2006cites this paper
• Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

  2005cites this paper
• Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease

  2005cites this paper
• Pharmaceutical liquid crystals: the relevance of partially ordered systems.

  2005cites this paper
• Controlling nonspecific protein adsorption in a plug-based microfluidic system by controlling interfacial chemistry using fluorous-phase surfactants.

  2005cites this paper
• Fibrillar amyloid beta-protein inhibits the activity of high molecular weight brain protease and trypsin

  2005cites this paper
• Protein aggregation and its inhibition in biopharmaceutics.

  2005cites this paper
• Role of melatonin in Alzheimer-like neurodegeneration 1

  2005cites this paper
• Structure and function of amyloid in Alzheimer's disease.

  2004cites this paper
• Mechanisms of soluble beta-amyloid impairment of endothelial function.

  2004cites this paper
• Beta-sheet breakers for Alzheimer's disease therapy.

  2004cites this paper
• Mechanisms of Soluble β-Amyloid Impairment of Endothelial Function*

  2004cites this paper
• [Immunotherapy of Alzheimer's disease. Results of experimental investigations and treatment of perspectives].

  2004cites this paper
• Protein aggregation studies: inhibiting and encouraging �-amyloid aggregation

  2004cites this paper
• Synthetic peptides in the diagnosis of neurological diseases.

  2003cites this paper
• Y10W β(1–40) fluorescence reflects epitope exposure in conformers of Alzheimer’s β-peptide

  2003cites this paper
• Quinolinic acid in the pathogenesis of Alzheimer's disease.

  2003cites this paper
• Y10W beta(1-40) fluorescence reflects epitope exposure in conformers of Alzheimer's beta-peptide.

  2003cites this paper
• 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonate: report on non-β-sheet conformers of Alzheimer's peptide β(1-40)

  2002cites this paper
• An investigation into the mechanisms mediating plasma lipoprotein‐potentiated β‐amyloid fibrillogenesis

  2002cites this paper
• Conformational changes preceding amyloid-fibril formation of amyloid-beta and stefin B; parallels in pH dependence.

  2002cites this paper
• 4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40).

  2002cites this paper
• A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell.

  2002cites this paper
• Cu2+ Inhibits the Aggregation of Amyloid β-Peptide(1-42) in vitro.

  2001cites this paper
• Distinct properties of wild‐type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type

  2001cites this paper
• Synthesis of amyloid β-peptides in solution employing chloroform-phenol mixed solvent for facile segment condensation of sparingly soluble protected peptides

  2001cites this paper
• beta-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease.

  2001cites this paper
• Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide.

  2001cites this paper
• β-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease

  2001cites this paper
• A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state.

  2001cites this paper
• Biochemical and structural studies of the prion protein polymorphism

  2001cites this paper